why choose us

First received: December 23, 2022

Clinical Trial: Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: COVID-19

Study Type: Interventional


Official Title: Safety and Effectiveness of SA58 Nasal Spray Against COVID-19 Infection in Medical Personnel?An Open-label, Blank-controlled Study

Brief Summary: This is an open, blank controlled clinical trial to evaluate the efficacy and safety of SA58 nasal spray in the prevention COVID-19 infection among health care workers at high risk of SARS-CoV-2 infection.

Read more